<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Huang X</submitter><funding>Science and Technology Department of Sichuan Province</funding><funding>National Natural Science Foundation of China</funding><funding>University of Texas MD Anderson Cancer Center</funding><pagination>e15939</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10189240</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(5)</volume><pubmed_abstract>BRAF mutation plays an important role in the pathogenesis and progression of melanoma and is correlated to the prognosis of melanoma patients. However, fewer studies have attempted to develop a BRAF mutation-associated gene risk model for predicting the prognosis of melanoma. The current research explores BRAF mutation-related biological features in melanoma and establishes a prognostic signature. First, we identified three significantly enriched KEGG pathways (glycosphingolipid biosynthesis - ganglio series, ether lipid metabolism, and glycosaminoglycan biosynthesis - keratan sulfate) and corresponding genes in the BRAF mutant group by gene set enrichment analysis. We then developed a prognostic signature based on 7 BRAF-associated genes (PLA2G2D, FUT8, PLA2G4E, PLA2G5, PLA2G1B, B3GNT2, a</pubmed_abstract><journal>Heliyon</journal><pubmed_title>A BRAF mutation-associated gene risk model for predicting the prognosis of melanoma.</pubmed_title><pmcid>PMC10189240</pmcid><funding_grant_id>PD-L1</funding_grant_id><funding_grant_id>38–41</funding_grant_id><funding_grant_id>PD-1</funding_grant_id><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Feng J</pubmed_authors><pubmed_authors>Huang X</pubmed_authors><pubmed_authors>Song Q</pubmed_authors><pubmed_authors>Jiang X</pubmed_authors><pubmed_authors>Gou W</pubmed_authors><pubmed_authors>Wen C</pubmed_authors><pubmed_authors>Bo X</pubmed_authors><pubmed_authors>Gao H</pubmed_authors></additional><is_claimable>false</is_claimable><name>A BRAF mutation-associated gene risk model for predicting the prognosis of melanoma.</name><description>BRAF mutation plays an important role in the pathogenesis and progression of melanoma and is correlated to the prognosis of melanoma patients. However, fewer studies have attempted to develop a BRAF mutation-associated gene risk model for predicting the prognosis of melanoma. The current research explores BRAF mutation-related biological features in melanoma and establishes a prognostic signature. First, we identified three significantly enriched KEGG pathways (glycosphingolipid biosynthesis - ganglio series, ether lipid metabolism, and glycosaminoglycan biosynthesis - keratan sulfate) and corresponding genes in the BRAF mutant group by gene set enrichment analysis. We then developed a prognostic signature based on 7 BRAF-associated genes (PLA2G2D, FUT8, PLA2G4E, PLA2G5, PLA2G1B, B3GNT2, a</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2026-05-28T10:49:19.694Z</modification><creation>2024-11-19T16:22:11.37Z</creation></dates><accession>S-EPMC10189240</accession><cross_references><pubmed>37205993</pubmed><doi>10.1016/j.heliyon.2023.e15939</doi></cross_references></HashMap>